Strides Pharma acquires FDA OK for generic butalbital, acetaminophen and caffeine

Press enter to search
Close search
Open Menu
The words approved in red and spelled out in capitals.

Strides Pharma acquires FDA OK for generic butalbital, acetaminophen and caffeine

By Sandra Levy - 10/13/2020

Patients seeking relief of the symptom complex of tension (or muscle contraction) headache will soon have a new generic treatment.

Strides Pharma has received the Food and Drug Administration’s blessing for butalbital, acetaminophen, and caffeine tablets in a dosage strength of 50 mg/325 mg/40 mg.

The product is the generic of Actavis Laboratories’ butalbital, acetaminophen, and caffeine tablets.

It had a market value of roughly $40 million, according to IQVIA July 2020 data.

Related Topics